agilon health annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
agilon health Stock-Based Compensation Growth & History (AGL)
agilon health's stock-based compensation was $49.1M for fiscal 2025.
View full agilon health company overviewagilon health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $49.1M | −$1.5M | −3.04% |
| 2024 | 2024-12-31 | $50.7M | −$18.8M | −27.11% |
| 2023 | 2023-12-31 | $69.5M | $41.1M | +144.86% |
| 2022 | 2022-12-31 | $28.4M | −$264.0M | −90.29% |
| 2021 | 2021-12-31 | $292.4M | $285.7M | +4271.92% |
| 2020 | 2020-12-31 | $6.7M | $1.5M | +28.00% |
| 2019 | 2019-12-31 | $5.2M | — | — |
agilon health quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $23.8M | $8.5M | +54.94% |
| Q1 2026 | 2026-03-31 | $6.3M | −$10.5M | −62.59% |
| Q4 2025 | 2025-12-31 | $9.5M | $7.2M | +317.18% |
| Q3 2025 | 2025-09-30 | $7.5M | −$5.8M | −43.45% |
| Q2 2025 | 2025-06-30 | $15.4M | −$2.8M | −15.52% |
| Q1 2025 | 2025-03-31 | $16.7M | −$189,000 | −1.12% |
| Q4 2024 | 2024-12-31 | $2.3M | −$13.2M | −85.29% |
| Q3 2024 | 2024-09-30 | $13.3M | −$7.5M | −36.06% |
| Q2 2024 | 2024-06-30 | $18.2M | −$1.4M | −6.97% |
| Q1 2024 | 2024-03-31 | $16.9M | $3.2M | +23.68% |
| Q4 2023 | 2023-12-31 | $15.5M | $5.6M | +55.91% |
| Q3 2023 | 2023-09-30 | $20.7M | $12.8M | +162.25% |
| Q2 2023 | 2023-06-30 | $19.6M | $13.0M | +198.67% |
| Q1 2023 | 2023-03-31 | $13.7M | $9.7M | +244.38% |
| Q4 2022 | 2022-12-31 | $10.0M | $5.5M | +125.44% |
| Q3 2022 | 2022-09-30 | $7.9M | −$4.1M | −33.89% |
| Q2 2022 | 2022-06-30 | $6.6M | −$268.0M | −97.61% |
| Q1 2022 | 2022-03-31 | $4.0M | $2.5M | +169.70% |
| Q4 2021 | 2021-12-31 | $4.4M | $2.6M | +149.38% |
| Q3 2021 | 2021-09-30 | $12.0M | $10.3M | +640.10% |
| Q2 2021 | 2021-06-30 | $274.5M | $272.3M | +12206.05% |
| Q1 2021 | 2021-03-31 | $1.5M | $401,000 | +37.44% |
| Q4 2020 | 2020-12-31 | $1.8M | — | — |
| Q3 2020 | 2020-09-30 | $1.6M | — | — |
| Q2 2020 | 2020-06-30 | $2.2M | — | — |
| Q1 2020 | 2020-03-31 | $1.1M | — | — |
agilon health stock-based compensation trends
Over the last five fiscal years, agilon health's stock-based compensation increased from $6.7M to $49.1M, a change of $42.4M. The latest reported quarter, Q2 2026, shows $23.8M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review agilon health source filings ↗